The 7 references in paper M. Lyakina N., E. Kovaleva L., O. Nikolaeva B., N. Krutikova M., N. Olenina G., L. Kolganov A., М. Лякина Н., Е. Ковалева Л., О. Николаева Б., Н. Крутикова М., Н. Оленина Г., Л. Колганов А. (2018) “Группировочные наименования лекарственных растительных средств: необходимость введения, рациональность формирования // Group names for herbal medicines: the need for introduction and rationale for establishing” / spz:neicon:vedomostincesmp:y:2016:i:3:p:9-11

1
WHO Drug Information. WHO. Geneva.
(check this in PDF content)
2
International Nonproprietary Names for Pharmaceutical Substance. Cumulative List 2007; 12. WHO. Geneva.
(check this in PDF content)
3
Loshakov LA. The system of national and international nonproprietary names of medicines. Vestnik Roszdravnadzora 2008; (6): 31–3 (in Russian).
(check this in PDF content)
4
On approval of the appointment and prescribing drugs, as well as forms of prescription for drugs, procedures for obtaining these forms, their recording and storage. Order of the Ministry of Health of the Russian Federation ¹ 1175n, 20.12.2012 (in Russian).
(check this in PDF content)
5
Guidelines on the Use of International Nonproprietary Names (INNs) for Pharmaceutical Substances. 1997. WHO/PHARM S/NOM 1570.
(check this in PDF content)
6
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJL 311, 28.11.2001, p. 67).
(check this in PDF content)
7
Available from: https://yadi.sk/d/euzr-wosnqEcw. AUTHORS Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, Petrovsky boulevard 8, bld. 2, Moscow 127051, Russian Federation. Lyakina MN. Deputy Head of Evaluation Office¹3oftheCentre for Evaluation and Control of Finished Pharmaceutical Products. Doctor of
(check this in PDF content)